Hjem › Brystkreft › California › Santa Monica
Kliniske studier for Brystkreft i Santa Monica, CA
28 studier for Brystkreft søker deltakere på steder i og rundt Santa Monica (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruttererFase 3
- Beverly Hills Cancer Center, Beverly Hills · 6 mi unna
A Study of PHST001 in Advanced Solid Tumors
RekruttererFase 1
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mi unna
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RekruttererFase 2
- Beverly Hills Cancer Center, Beverly Hills · 6 mi unna
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RekruttererFase 1
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Kivu Trial Site, Santa Monica
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekrutterer
- UCLA David Geffen School of Medicine, Santa Monica
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
RekruttererFase 1
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · 6 mi unna
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruttererFase 3
- Clinical Trial Site, Beverly Hills · 6 mi unna
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruttererFase 1
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruttererFase 3
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
RekruttererFase 2
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RekruttererFase 1/2
- Beverly Hills Cancer Center, Beverly Hills · 6 mi unna
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruttererFase 3
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruttererFase 3
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills · 6 mi unna
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RekruttererFase 1/2
- Research Site, Santa Monica
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
RekruttererFase 2
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruttererFase 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- og 1 flere
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Tower Cancer Research Foundation, Beverly Hills · 6 mi unna
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 mi unna
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mi unna
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
RekruttererFase 1
- Precision Next Gen Oncology & Research Center, Beverly Hills · 6 mi unna
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
RekruttererFase 2
- CS Cancer at Valley Oncology Medical Group, Tarzana · 11 mi unna
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruttererFase 3
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
RekruttererFase 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mi unna
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruttererFase 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · 4 mi unna
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mi unna
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekruttererFase 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
RekruttererFase 1
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 mi unna
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RekruttererFase 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
RekruttererObservasjonsstudie
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Santa Monica
- Ikke-småcellet lungekreft45 studier
- Kolorektal kreft23 studier
- Kreft (alle typer)22 studier
- Metastatisk kreft19 studier
- Lungekreft15 studier
- Eggstokkreft15 studier
- Prostatakreft15 studier
- Plateepitelcancer i hode og hals13 studier
- Hjertesvikt11 studier
- Endometriekreft10 studier
- Mavekreft9 studier
- Pankreaskreft9 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.